| Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards … JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ... Neurology 66 (7), 996-1002, 2006 | 678 | 2006 |
| Brain networks associated with cognitive reserve in healthy young and old adults Y Stern, C Habeck, J Moeller, N Scarmeas, KE Anderson, HJ Hilton, ... Cerebral cortex 15 (4), 394-402, 2005 | 546 | 2005 |
| The clinically important difference on the unified Parkinson's disease rating scale LM Shulman, AL Gruber-Baldini, KE Anderson, PS Fishman, SG Reich, ... Archives of neurology 67 (1), 64-70, 2010 | 538 | 2010 |
| Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease LM Shulman, LI Katzel, FM Ivey, JD Sorkin, K Favors, KE Anderson, ... JAMA neurology 70 (2), 183-190, 2013 | 439 | 2013 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 418 | 2012 |
| Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis N Scarmeas, E Zarahn, KE Anderson, CG Habeck, J Hilton, J Flynn, ... Archives of neurology 60 (3), 359-365, 2003 | 375 | 2003 |
| The evolution of disability in Parkinson disease LM Shulman, AL Gruber‐Baldini, KE Anderson, CG Vaughan, SG Reich, ... Movement disorders 23 (6), 790-796, 2008 | 346 | 2008 |
| Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 332 | 2015 |
| Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease GM Pontone, JR Williams, KE Anderson, G Chase, SA Goldstein, S Grill, ... Movement disorders: official journal of the Movement Disorder Society 24 (9 …, 2009 | 328 | 2009 |
| Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY) E van Duijn, D Craufurd, AAM Hubers, EJ Giltay, R Bonelli, H Rickards, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1411-1418, 2014 | 304 | 2014 |
| Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer˘s disease DA Wolk, BC Dickerson, Alzheimer˘s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 274 | 2010 |
| Subregional neuroanatomical change as a biomarker for Alzheimer's disease D Holland, JB Brewer, DJ Hagler, C Fennema-Notestine, AM Dale, ... Proceedings of the National Academy of Sciences 106 (49), 20954-20959, 2009 | 244 | 2009 |
| Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects N Scarmeas, E Zarahn, KE Anderson, J Hilton, J Flynn, RL Van Heertum, ... Neuroimage 19 (3), 1215-1227, 2003 | 206 | 2003 |
| Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study HH Fernandez, SA Factor, RA Hauser, J Jimenez-Shahed, WG Ondo, ... Neurology 88 (21), 2003-2010, 2017 | 192 | 2017 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| A comparison of nine scales to detect depression in Parkinson disease: which scale to use? JR Williams, ES Hirsch, K Anderson, AL Bush, SR Goldstein, S Grill, ... Neurology 78 (13), 998-1006, 2012 | 181 | 2012 |
| Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial KE Anderson, D Stamler, MD Davis, SA Factor, RA Hauser, J Isojärvi, ... The Lancet Psychiatry 4 (8), 595-604, 2017 | 180 | 2017 |
| Vascular burden and Alzheimer disease pathologic progression RY Lo, WJ Jagust, M Weiner, P Aisen, M Weiner, P Aisen, R Petersen, ... Neurology 79 (13), 1349-1355, 2012 | 180 | 2012 |
| Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial S Frank, CM Testa, D Stamler, E Kayson, C Davis, MC Edmondson, ... Jama 316 (1), 40-50, 2016 | 177 | 2016 |
| Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy EE Sundermann, A Biegon, LH Rubin, RB Lipton, W Mowrey, S Landau, ... Neurology 86 (15), 1368-1376, 2016 | 161 | 2016 |
Ann Gruber-BaldiniUniversity of Maryland School of MedicineVerified email at som.umaryland.edu
